May 9, 2019JAMA OncologyOpen Access

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

View Full Paper

Ask AI

Bookmark

Circulating tumor DNA analysis may improve postoperative management for colorectal cancer.
Study indicates enhanced risk stratification and early relapse detection through ultradeep sequencing.
Assessment utilized ultradeep sequencing to analyze plasma cell-free DNA from patients with colorectal cancer stages I to III, providing crucial insights into their condition and treatment plans. This approach enables better monitoring of adjuvant chemotherapy in patients after surgery for colorectal cancer.

Implication

Analysis of circulating tumor DNA demonstrates effective postoperative management in colorectal cancer, suggesting improved outcomes.

Abstract

Circulating tumor DNA analysis can potentially change the postoperative management of CRC by enabling risk stratification, ACT monitoring, and early relapse detection.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reinert et al. (2019) studied this question.

synapsesocial.com/papers/690e646686de104c2a6f51fc https://doi.org/10.1001/jamaoncol.2019.0528

View Full Paper

Ask AI

Bookmark

Implication

Analysis of circulating tumor DNA demonstrates effective postoperative management in colorectal cancer, suggesting improved outcomes.

Abstract

Circulating tumor DNA analysis can potentially change the postoperative management of CRC by enabling risk stratification, ACT monitoring, and early relapse detection.

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading